PMID- 35042215 OWN - NLM STAT- MEDLINE DCOM- 20220603 LR - 20220924 IS - 1423-0097 (Electronic) IS - 1018-2438 (Print) IS - 1018-2438 (Linking) VI - 183 IP - 6 DP - 2022 TI - Development of Sensitization to Multiple Allergen Molecules from Preschool to School Age Is Related to Asthma. PG - 628-639 LID - 10.1159/000521324 [doi] AB - INTRODUCTION: Allergic sensitization in early life has been identified as a strong risk factor for subsequent asthma in childhood. It is still unclear why only a part of sensitized children develop asthma, and the role of specific allergen molecules in asthma pathogenesis is ambiguous [Pharmacol Ther. 2009 Feb;121(2):174-84]. We assessed the sensitization to multiple allergen molecules longitudinally and explored its relation to persistent asthma at 7 years. METHODS: Seventy-two children included during an acute wheezing episode (cases) were followed prospectively from early preschool age (EPA) to age 7, and compared to 43 healthy controls at EPA. Allergen molecules were analyzed at EPA and age 7 using ImmunoCAP Solid-phase Allergen Chip (ISAC). Asthma diagnosis at 7 years was based on symptoms, medication, and spirometry. RESULTS: At EPA, cases compared to controls showed a tendency toward having a higher prevalence of allergic sensitization (23.6% vs. 9.3%, p = 0.055). The prevalence of sensitization increased in cases from EPA to 7 years (23.6% vs. 38.9%; p = 0.048) as well as the median number (range) of immunoglobulin E (IgE)-reactive molecules 3 (3-14) versus 6.5 (1-21); p = 0.024. Sensitization to each additional molecule from EPA to the age of 7 was significantly related to asthma at 7 (OR = 1.25, 95% confidence interval [1.01, 1.54]). CONCLUSION: Polysensitization, assessed by allergen molecules, had a significant impact on persistent asthma at school age. The extent of sensitization, illustrated by molecular spreading from preschool to school age, was related to asthma diagnosis at 7 years in children with a history of wheezing at early life. CI - (c) 2022 The Author(s). Published by S. Karger AG, Basel. FAU - Filiou, Anastasia AU - Filiou A AD - Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden. AD - Astrid Lindgren's Children's Hospital, Karolinska University Hospital, Stockholm, Sweden. FAU - Holmdahl, Idun AU - Holmdahl I AD - Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden. AD - Astrid Lindgren's Children's Hospital, Karolinska University Hospital, Stockholm, Sweden. FAU - Asarnoj, Anna AU - Asarnoj A AD - Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden. AD - Astrid Lindgren's Children's Hospital, Karolinska University Hospital, Stockholm, Sweden. FAU - van Hage, Marianne AU - van Hage M AD - Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. FAU - Ekenkrantz, Tina AU - Ekenkrantz T AD - Thermo Fisher Scientific, Uppsala, Sweden. FAU - Rydell, Niclas AU - Rydell N AD - Thermo Fisher Scientific, Uppsala, Sweden. FAU - Sjolander, Anders AU - Sjolander A AD - Thermo Fisher Scientific, Uppsala, Sweden. FAU - Stenberg-Hammar, Katarina AU - Stenberg-Hammar K AD - Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden. AD - Astrid Lindgren's Children's Hospital, Karolinska University Hospital, Stockholm, Sweden. FAU - Hedlin, Gunilla AU - Hedlin G AD - Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden. AD - Astrid Lindgren's Children's Hospital, Karolinska University Hospital, Stockholm, Sweden. FAU - Konradsen, Jon R AU - Konradsen JR AD - Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden. AD - Astrid Lindgren's Children's Hospital, Karolinska University Hospital, Stockholm, Sweden. FAU - Soderhall, Cilla AU - Soderhall C AD - Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden. AD - Astrid Lindgren's Children's Hospital, Karolinska University Hospital, Stockholm, Sweden. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220118 PL - Switzerland TA - Int Arch Allergy Immunol JT - International archives of allergy and immunology JID - 9211652 RN - 0 (Allergens) RN - 37341-29-0 (Immunoglobulin E) SB - IM MH - *Allergens MH - *Asthma/diagnosis/epidemiology MH - Child MH - Child, Preschool MH - Humans MH - Immunoglobulin E MH - Respiratory Sounds MH - Spirometry PMC - PMC9227676 OTO - NOTNLM OT - Allergen molecules OT - Allergic sensitization OT - Asthma OT - Longitudinal OT - Polysensitization OT - Preschool wheeze COIS- Anastasia Eleni Filiou, Idun Holmdahl, Anna Asarnoj, Katarina Stenberg-Hammar, and Gunilla Hedlin have no conflicts of interest to declare. Marianne van Hage reports personal fees from Thermo Fisher Scientific, outside the submitted work. Niclas Rydell, Tina Ekencrantz, and Anders Sjolander are employees of Thermo Fisher Scientific. Dr Konradsen and Dr. Soderhall report nonfinancial support from Thermo Fisher Scientific, during the conduct of the study. EDAT- 2022/01/19 06:00 MHDA- 2022/06/07 06:00 PMCR- 2022/01/18 CRDT- 2022/01/18 20:28 PHST- 2021/09/24 00:00 [received] PHST- 2021/11/12 00:00 [accepted] PHST- 2022/01/19 06:00 [pubmed] PHST- 2022/06/07 06:00 [medline] PHST- 2022/01/18 20:28 [entrez] PHST- 2022/01/18 00:00 [pmc-release] AID - 000521324 [pii] AID - iaa-0183-0628 [pii] AID - 10.1159/000521324 [doi] PST - ppublish SO - Int Arch Allergy Immunol. 2022;183(6):628-639. doi: 10.1159/000521324. Epub 2022 Jan 18.